iQMR
Medic Vision - Imaging Solutions Ltd • Radiology • 03/08/2018
Device Purpose
The iQMR is a software-based medical device intended to improve MRI image quality by reducing noise through proprietary processing algorithms operating on a PC server. This DICOM-compatible system enhances images for clinical review, with a stated limitation that its processing is not effective for abnormalities smaller than 1.5mm.
Summary
The iQMR system is a software package designed for networking, communication, and the processing and enhancement of Magnetic Resonance Imaging (MRI) images provided in DICOM format. Its core function is to improve the quality of MRI images by reducing image noise. The software operates on a standard PC server running a Linux Ubuntu operating system and consists of three primary modules: User Interface, Algorithm, and Interface. It is architected to receive MRI images from various network workstations, process them using its proprietary algorithms, and then transmit the enhanced DICOM-formatted images back to selected workstations for review by medical professionals. The device's processing capability has a specified limitation, in that it is not effective for lesions, masses, or abnormalities smaller than 1.5mm. The iQMR is intended for use by qualified medical professionals trained in its operation. While formal clinical trials were not conducted, the system underwent non-clinical performance verification using MRI standard phantoms and predefined software test plans. Furthermore, its performance was validated by processing actual clinical MRI images to ensure it meets user needs and its intended applications within an end-user environment.
AI Regulatory Concerns
Powered by
Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.
Keywords
Device Metadata
Relevant Clinical Questions
- Q1. What specific noise reduction algorithms are utilized by the iQMR software, and how do they compare to other commercially available techniques?; How was the 1.5mm threshold for effective lesion/mass processing determined, and what is the performance degradation for features slightly above or below this size?; What quantitative metrics were used to validate the 'enhancement' of MRI images and 'reduction of image noise' during phantom and clinical image processing tests?; Are there specific MRI sequences or imaging parameters for which iQMR processing is optimally effective or, conversely, less effective?; What is the typical processing time per MRI study, and how does this integrate into a high-volume clinical workflow?
Risk Classification
ESL AnalysisFDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Authorized before §524B enforcement
Learn how Parasoft automates IEC 62304 compliance testing →Cybersecurity Evidence
Powered by SBOMator™Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.
Supply Chain BOM Evidence
Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.
Analysis:
• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.
• Evidence of SBOM, ML-BOM, SaaSBOM, OBOM detected in AI-generated device summary.
• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.
• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.
• Not detected in AI-generated device summary: HBOM, CBOM, VDR/VEX. These may be present in the full FDA submission.
Preparing a similar submission?
ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.
Assess Your Readiness →Or contact ESL directly